Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 376–390 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5572 CCDC103 Gene Primary Ciliary Dyskinesia (PCD Type 17) Genetic Test This genetic test identifies pathogenic variants in the CCDC103 gene associated with primary ciliary dyskinesia type 17.	Whole blood (3–5 mL in EDTA tube), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CCDC103 gene", "Ciliary function impairment"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected primary ciliary dyskinesia", "Family history of PCD", "Recurrent respiratory infections"] Measurement technique Confirm with laboratory Codes LOINC: 82163-6 ICD-10: Q89.9, J98.9 Clinical summary This genetic test identifies pathogenic variants in the CCDC103 gene associated with primary ciliary dyskinesia type 17.
TEST-5564 CCDC114 Gene Primary Ciliary Dyskinesia Genetic Test (NGS) This test identifies pathogenic variants in the CCDC114 gene associated with Primary Ciliary Dyskinesia type 20.	Whole Blood, Buccal Swab, or Dried Blood Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CCDC114 gene"] Parameters [] Preparation ["Detailed clinical evaluation recommended", "Genetic counselling session advised"] Indications ["Clinical suspicion of Primary Ciliary Dyskinesia (PCD)", "Family history of PCD", "Situs inversus", "Recurrent sino-pulmonary infections", "Infertility evaluation"] Measurement technique Confirm with laboratory Codes LOINC: 94807-4 ICD-10: Q34.8 Clinical summary This test identifies pathogenic variants in the CCDC114 gene associated with Primary Ciliary Dyskinesia type 20.
TEST-3885 CCDC28B Gene Bardet‑Biedl Syndrome Modifier NGS Test This test identifies pathogenic variants in the CCDC28B gene, a known modifier gene associated with Bardet‑Biedl syndrome.	Whole Blood (peripheral), FTA Card, or Extracted DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCDC28B gene sequence", "Pathogenic variants"] Parameters [] Preparation ["Mandatory genetic counseling session", "Document clinical history", "Chart pedigree of affected family members"] Indications ["Suspected Bardet‑Biedl syndrome", "Family history of Bardet‑Biedl syndrome", "Evaluation of multi-systemic ciliopathy"] Measurement technique Confirm with laboratory Codes LOINC: 99058-9 ICD-10: Q87.89, Z13.79, Z14.8 Clinical summary This test identifies pathogenic variants in the CCDC28B gene, a known modifier gene associated with Bardet‑Biedl syndrome.
TEST-5524 CCDC39 Gene — Primary Ciliary Dyskinesia Type 14 — Genetic Test This genetic test analyzes the CCDC39 gene to identify mutations causing Primary Ciliary Dyskinesia Type 14 (PCD14). It detects single nucleotide variants, small insertions/deletio...	Peripheral whole blood (EDTA) or dried blood spot on FTA card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCDC39 gene sequence", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No special fasting required", "Do not stop any medications prior to collection"] Indications ["Clinical suspicion of Primary Ciliary Dyskinesia Type 14", "Family history of PCD14", "Carrier screening in relatives of affected individuals"] Measurement technique Confirm with laboratory Codes LOINC: 48018-6 ICD-10: Q34.8 Clinical summary This genetic test analyzes the CCDC39 gene to identify mutations causing Primary Ciliary Dyskinesia Type 14 (PCD14). It detects single nucleotide variants, small insertions/deletions, and copy number changes.
TEST-5576 CCDC40 Gene Analysis (Primary Ciliary Dyskinesia Type 15) Genetic Test This test identifies pathogenic variants in the CCDC40 gene associated with Primary Ciliary Dyskinesia Type 15.	Peripheral whole blood (3–5 mL) or FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCDC40 gene sequence", "Copy Number Variations (CNVs) in CCDC40 gene"] Parameters [] Preparation ["No fasting required", "Provide detailed clinical history", "Pre-genetic counseling session recommended"] Indications ["Suspected Primary Ciliary Dyskinesia Type 15", "Family history of Primary Ciliary Dyskinesia", "Chronic respiratory symptoms", "Recurrent ear infections", "Infertility investigation"] Measurement technique Confirm with laboratory Codes LOINC: 21665-6 ICD-10: Q34.8 Clinical summary This test identifies pathogenic variants in the CCDC40 gene associated with Primary Ciliary Dyskinesia Type 15.
TEST-5685 CCDC50 Gene (Deafness, Autosomal Dominant Type 44) Genetic Test This genetic test analyzes the CCDC50 gene to detect mutations causing autosomal dominant nonsyndromic hearing loss (DFNA44). It uses Next-Generation Sequencing (NGS) for comprehen...	Whole Blood (Peripheral)	21–28 business days (3–4 weeks)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCDC50 gene sequence", "Single nucleotide variants", "Insertions", "Deletions", "Copy number variations"] Parameters [] Preparation ["No specific fasting required", "Avoid recent blood transfusion or bone marrow transplant (within 12 weeks)"] Indications ["Suspected autosomal dominant nonsyndromic hearing loss (DFNA44)", "Family history of DFNA44", "Genetic counseling for hereditary hearing loss"] Measurement technique Confirm with laboratory Codes LOINC: 81287-4 ICD-10: H90.3 Clinical summary This genetic test analyzes the CCDC50 gene to detect mutations causing autosomal dominant nonsyndromic hearing loss (DFNA44). It uses Next-Generation Sequencing (NGS) for comprehensive analysis.
TEST-5497 CCDC65 Gene Primary Ciliary Dyskinesia Type 27 Genetic Test This test evaluates the CCDC65 gene for pathogenic variants associated with Primary Ciliary Dyskinesia Type 27.	Whole Blood, Extracted DNA, or FTA Card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CCDC65 gene", "Ciliary motility defects (indirectly)"] Parameters [] Preparation ["No fasting required", "Ensure prior radiological and microbiological reports are available"] Indications ["Diagnosis of Primary Ciliary Dyskinesia Type 27", "Family planning for individuals with PCD", "Confirmation of molecular basis for suspected PCD"] Measurement technique Confirm with laboratory Codes LOINC: 94194-6 ICD-10: J98.4; Q34.8 Clinical summary This test evaluates the CCDC65 gene for pathogenic variants associated with Primary Ciliary Dyskinesia Type 27.
TEST-3959 CCDC78 Gene Centronuclear Myopathy Type 4 Genetic Test This test evaluates the CCDC78 gene for pathogenic variants associated with autosomal recessive centronuclear myopathy type 4.	Peripheral whole blood (EDTA tube)	21–28 days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CCDC78 gene"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your doctor."] Indications ["Clinical suspicion of congenital myopathy", "Autosomal recessive centronuclear myopathy type 4"] Measurement technique Confirm with laboratory Codes LOINC: 97996-0 ICD-10: G71.2, G71.20 Clinical summary This test evaluates the CCDC78 gene for pathogenic variants associated with autosomal recessive centronuclear myopathy type 4.
TEST-2235 CCDC8 Gene Sequencing for 3‑M Syndrome Type 3 (NGS) Test This test analyzes the CCDC8 gene for pathogenic variants associated with 3-M syndrome type 3.	Whole Blood (2–3 mL) or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CCDC8 gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy-number changes"] Parameters [] Preparation ["Prior genetic counselling is mandatory", "Detailed clinical history required"] Indications ["Suspected 3-M syndrome type 3 based on clinical features", "Dysmorphology evaluation", "Genetic counseling for families with suspected 3-M syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 76479-2 ICD-10: Q87.1 Clinical summary This test analyzes the CCDC8 gene for pathogenic variants associated with 3-M syndrome type 3.
TEST-4530 CCDC88C Gene Hydrocephalus, Nonsyndromic, Autosomal Recessive Type 1 Genetic Test This test identifies pathogenic variants in the CCDC88C gene associated with nonsyndromic, autosomal recessive hydrocephalus type 1.	Peripheral whole blood (EDTA) or FTA card	15–21 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCDC88C gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist about anticoagulant therapy"] Indications ["Suspected autosomal recessive hydrocephalus type 1", "Family history of hydrocephalus"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Q03.8 Clinical summary This test identifies pathogenic variants in the CCDC88C gene associated with nonsyndromic, autosomal recessive hydrocephalus type 1.
TEST-4020 CCM2 Gene Sequencing for Cerebral Cavernous Malformations Type 2 (Genetic Test) This genetic test analyzes the CCM2 gene to identify mutations associated with cerebral cavernous malformations type 2.	Peripheral blood (3–5 mL in EDTA tube), dried blood spot on FTA card, or extracted genomic DNA (≥1 µg at ≥50 ng/µL)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CCM2 gene", "Single nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy-number alterations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Do not alter or discontinue prescribed therapy without consulting your physician"] Indications ["Individuals with multiple cavernous malformations on MRI", "Family history of CCM", "First-degree relatives of a proband with a confirmed CCM2 mutation"] Measurement technique Confirm with laboratory Codes LOINC: 92966-6 ICD-10: Q28.3, Z82.3, Z15.89 Clinical summary This genetic test analyzes the CCM2 gene to identify mutations associated with cerebral cavernous malformations type 2.
TEST-2113 CCND1 Gene Hereditary Colorectal Cancer Susceptibility Genetic Test This genetic test evaluates the CCND1 gene for mutations that increase the risk of developing hereditary colorectal cancer.	Peripheral Whole Blood or FTA Card (Dried Blood Spot)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCND1 gene mutations", "Germline genetic variants"] Parameters [] Preparation [] Indications ["Family history of colorectal cancer", "Early-onset colorectal cancer", "Multiple primary cancers"] Measurement technique Confirm with laboratory Codes LOINC: 78999-1 ICD-10: Z15.09 Clinical summary This genetic test evaluates the CCND1 gene for mutations that increase the risk of developing hereditary colorectal cancer.
TEST-5493 CCNO Gene Primary Ciliary Dyskinesia Type 29 Genetic Test This test identifies mutations in the CCNO gene associated with primary ciliary dyskinesia type 29.	Peripheral Whole Blood (Venipuncture), Extracted DNA, or FTA Card Blood Spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CCNO gene mutations", "Point mutations", "Indels", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["Continue all prescribed respiratory medications", "No medication washout required"] Indications ["Suspected primary ciliary dyskinesia type 29", "Family history of primary ciliary dyskinesia", "Need for definitive molecular diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 88507-1 ICD-10: J98.4 Clinical summary This test identifies mutations in the CCNO gene associated with primary ciliary dyskinesia type 29.
TEST-5483 CCT5 Gene Neuropathy (Hereditary Sensory with Spastic Paraplegia) Genetic Test This genetic test evaluates the CCT5 gene for pathogenic variants associated with hereditary sensory neuropathy with spastic paraplegia.	Peripheral whole blood, DNA, or FTA card	3 to 4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CCT5 gene", "Full coding region analysis"] Parameters [] Preparation [] Indications ["Diagnosis of hereditary sensory neuropathy with spastic paraplegia", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 91553-4 ICD-10: G60.8 Clinical summary This genetic test evaluates the CCT5 gene for pathogenic variants associated with hereditary sensory neuropathy with spastic paraplegia.
TEST-4900 CD247 Gene Immunodeficiency Type 25 Genetic Test This genetic test analyzes the CD247 gene for pathogenic variants associated with primary combined immunodeficiency type 25.	Whole Blood (EDTA), Extracted DNA (≥ 500 ng), or One Drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CD247 gene sequence", "Copy Number Variations (CNVs) in CD247"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any current medications"] Indications ["Suspected primary combined immunodeficiency", "Family history of immunodeficiency", "Evaluation of specific dermatological or oncological conditions"] Measurement technique Confirm with laboratory Codes LOINC: 81309-3 ICD-10: D81.9 Clinical summary This genetic test analyzes the CD247 gene for pathogenic variants associated with primary combined immunodeficiency type 25.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories